Clinical Trials Browser

Phase 1 × NSCLC × 90 days × Clear all

NCT05615142 2026-05-11

Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.

Phase 1 Active not recruiting

NSCLC